Literature DB >> 21569796

Polyclonal antibodies against properly folded Dengue virus NS1 protein expressed in E. coli enable sensitive and early dengue diagnosis.

Diego Allonso1, Marcela da Silva Rosa, Diego Rodrigues Coelho, Simone Morais da Costa, Rita Maria Ribeiro Nogueira, Fernando Augusto Bozza, Flavia Barreto Dos Santos, Ada Maria de Barcelos Alves, Ronaldo Mohana-Borges.   

Abstract

The non-structural 1 (NS1) protein plays an important role in dengue diagnosis because it has been detected as a soluble serum antigen in both primary and secondary infections. The NS1 protein was expressed in Escherichia coli cells, and the efficiency of four different refolding protocols was tested. All of the protocols generated dimeric NS1 in a conformation similar to that of the protein expressed by eukaryotic cells. A polyclonal antibody produced from the properly folded E. coli recombinant NS1 (rNS1) protein proved to be a useful tool for the diagnosis of Dengue virus because it detected 100% of the Dengue virus 2 (DENV2) in infected patients' sera and 60% of the DENV IgM-positive sera not detected by commercial NS1-based diagnostic kits. These data suggest a high-efficiency method for correctly folding rNS1 that maintains its structural and immunogenic properties. In addition, a detection method using the polyclonal antibody against correctly folded rNS1 seemed to be more sensitive and efficient for NS1 detection in serum, highlighting its usefulness for developing a high-sensitivity diagnostic kit.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21569796     DOI: 10.1016/j.jviromet.2011.04.029

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  12 in total

Review 1.  Dengue virus: a review on advances in detection and trends - from conventional methods to novel biosensors.

Authors:  Reza Eivazzadeh-Keihan; Paria Pashazadeh-Panahi; Tohid Mahmoudi; Karim Khanmohammadi Chenab; Behzad Baradaran; Mahmoud Hashemzaei; Fateme Radinekiyan; Ahad Mokhtarzadeh; Ali Maleki
Journal:  Mikrochim Acta       Date:  2019-05-04       Impact factor: 5.833

2.  Dengue Virus NS1 Protein Modulates Cellular Energy Metabolism by Increasing Glyceraldehyde-3-Phosphate Dehydrogenase Activity.

Authors:  Diego Allonso; Iamara S Andrade; Jonas N Conde; Diego R Coelho; Daniele C P Rocha; Manuela L da Silva; Gustavo T Ventura; Emiliana M Silva; Ronaldo Mohana-Borges
Journal:  J Virol       Date:  2015-09-16       Impact factor: 5.103

3.  Determination of viremia and concentration of circulating nonstructural protein 1 in patients infected with dengue virus in Mexico.

Authors:  Sergio I de la Cruz-Hernández; Hilario Flores-Aguilar; Silvia González-Mateos; Irma López-Martinez; Celia Alpuche-Aranda; Juan E Ludert; Rosa M del Angel
Journal:  Am J Trop Med Hyg       Date:  2013-01-21       Impact factor: 2.345

4.  Inflammatory signaling in dengue-infected platelets requires translation and secretion of nonstructural protein 1.

Authors:  Anna Cecíllia Quirino-Teixeira; Stephane Vicente Rozini; Giselle Barbosa-Lima; Diego Rodrigues Coelho; Pedro Henrique Carneiro; Ronaldo Mohana-Borges; Patrícia T Bozza; Eugenio D Hottz
Journal:  Blood Adv       Date:  2020-05-12

5.  Inhibition of the Membrane Attack Complex by Dengue Virus NS1 through Interaction with Vitronectin and Terminal Complement Proteins.

Authors:  Jonas Nascimento Conde; Emiliana Mandarano da Silva; Diego Allonso; Diego Rodrigues Coelho; Iamara da Silva Andrade; Luciano Neves de Medeiros; Joice Lima Menezes; Angela Silva Barbosa; Ronaldo Mohana-Borges
Journal:  J Virol       Date:  2016-10-14       Impact factor: 5.103

6.  ApoA1 Neutralizes Proinflammatory Effects of Dengue Virus NS1 Protein and Modulates Viral Immune Evasion.

Authors:  Diego R Coelho; Pedro H Carneiro; Lucas Mendes-Monteiro; Jonas N Conde; Iamara Andrade; Thu Cao; Diego Allonso; Michael White-Dibiasio; Richard J Kuhn; Ronaldo Mohana-Borges
Journal:  J Virol       Date:  2021-06-10       Impact factor: 5.103

7.  Development of VHH antibodies against dengue virus type 2 NS1 and comparison with monoclonal antibodies for use in immunological diagnosis.

Authors:  Aneela Fatima; Haiying Wang; Keren Kang; Liliang Xia; Ying Wang; Wei Ye; Jufang Wang; Xiaoning Wang
Journal:  PLoS One       Date:  2014-04-21       Impact factor: 3.240

8.  Assessing positivity and circulating levels of NS1 in samples from a 2012 dengue outbreak in Rio de Janeiro, Brazil.

Authors:  Diego Allonso; Marcelo D F Meneses; Carlos A Fernandes; Davis F Ferreira; Ronaldo Mohana-Borges
Journal:  PLoS One       Date:  2014-11-20       Impact factor: 3.240

9.  Development and characterization of serotype-specific monoclonal antibodies against the dengue virus-4 (DENV-4) non-structural protein (NS1).

Authors:  Tesfaye Gelanew; Elizabeth Hunsperger
Journal:  Virol J       Date:  2018-02-06       Impact factor: 4.099

10.  Mapping the interactions of dengue virus NS1 protein with human liver proteins using a yeast two-hybrid system: identification of C1q as an interacting partner.

Authors:  Emiliana M Silva; Jonas N Conde; Diego Allonso; Mauricio L Nogueira; Ronaldo Mohana-Borges
Journal:  PLoS One       Date:  2013-03-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.